Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide vs Insulin Lispro in T2D on Glargine
NCT04537923Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 16
01
Overview
A Phase 3 trial of tirzepatide in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Oct 2020; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04537923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04537923.